LakeShore Biopharma Co., Ltd
OTC: LSBCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Wang Xu
- Employees
- 758
- Headquarters
- Beijing, China
- IPO year
- 2021
- Market cap
- $2.8M
- Website
- https://www.ysbiopharm.com
Loading LSBCF…
Loading profile data…Frequently asked questions about LSBCF
What does LakeShore Biopharma Co., Ltd (LSBCF) do?
LakeShore Biopharma Co., Ltd (LSBCF) is a biopharmaceutical firm dedicated to the end-to-end process of bringing innovative medical solutions to market. Its primary focus lies in creating vaccines and advanced therapeutic biologics, specifically designed to combat infectious diseases and various forms of cancer. A cornerstone of its strategy is...
Where does LSBCF trade?
LakeShore Biopharma Co., Ltd (LSBCF) trades on the Other OTC.
What sector is LSBCF in?
LakeShore Biopharma Co., Ltd (LSBCF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of LakeShore Biopharma Co., Ltd?
Wang Xu is the chief executive officer of LakeShore Biopharma Co., Ltd (LSBCF).
Where is LakeShore Biopharma Co., Ltd headquartered?
LakeShore Biopharma Co., Ltd is headquartered in China.
Does LSBCF pay a dividend?
LakeShore Biopharma Co., Ltd (LSBCF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LSBCF go public?
LakeShore Biopharma Co., Ltd (LSBCF) completed its initial public offering in 2021.